Researchers have completed a new analysis of the Evolut Pro and Pro+ devices from Medtronic and the Sapien 3 Ultra devices from Edwards Lifesciences, sharing the results in JACC: Cardiovascular Interventions.

It is an announcement many interventional cardiologists have been waiting to hear for a long time. 

Following the DASH diet is associated with key health benefits, according to a new analysis published in the American Journal of Cardiology.

The new-look device, still under development, is designed to be worn for weeks at a time. 

Oversized devices are becoming more common as time goes on, which suggests operators are growing increasingly comfortable with this treatment choice.

A team of Mayo Clinic specialists led the analysis, sharing their findings in Nature Medicine.

Prior authorization, which requires healthcare providers to get approval from insurance providers before giving certain treatments to patients, has been long-hailed as extremely burdensome to physicians, even causing delays in patient care.

Here are some interesting new technologies and key trends from the vast expo floor at the Radiological Society of North America 2022 meeting.